AORT vs ENOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 17, 2026

AORT

32.3
AI Score
VS
ENOV Wins

ENOV

48.1
AI Score

Investment Advisor Scores

AORT

32score
Recommendation
SELL

ENOV

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AORT ENOV Winner
Forward P/E 163.9344 6.5703 ENOV
PEG Ratio 181.5 1.8989 ENOV
Revenue Growth 11.3% 3.2% AORT
Earnings Growth 0.0% 153.1% ENOV
Tradestie Score 32.3/100 48.1/100 ENOV
Profit Margin -0.7% -48.0% AORT
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD ENOV

Relative Price Performance (Last 90 Days)

AORT 1M: +12.3% · 3M: +23.3% ENOV 1M: +0.0% · 3M: +6.0%

Current Technical Phase

AORT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.1% over 20 days), RSI 57

RSI (14): 57.3 · Price: $28.08

ENOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $26.06

Fundamentals Snapshot

Metric AORT ENOV
Market Cap
Forward P/E 35.9 6.5
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.6%
Operating Margin 0.1% 0.0%
EPS -0.06 -19.27
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ENOV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.